How to appeal an Elevance Health sickle cell & thalassemia denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Elevance Health-specific note: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.

What Elevance Health's policy requires for sickle cell & thalassemia

Cited policy: BCBS plan-specific (Empire/Highmark/Florida Blue) gene therapy policies

FDA-approved + ATC + severe disease genotype + transfusion-dependent for TDT.

How Elevance Health denies sickle cell & thalassemia — and how to counter it

Where Elevance Health pushes back: 1) State plan more restrictive than FDA label; 2) ATC not in network; 3) Outcomes-based contract not finalized.

Counter-arguments that hold up: Pull plan-specific bulletin. Cite state insurance commissioner external review. NMDP donor search documentation if HSCT discussed. CMS CGT Access Model participation if Medicaid.

What Elevance Health typically denies for sickle cell & thalassemia

Across Elevance Health's commercial and Medicare books, denials cluster around a small number of patterns. For sickle cell & thalassemia, expect:

• Step therapy
• Medical necessity for biologics
• Out-of-network for behavioral health
• Bariatric surgery prior auth

Treatments most often denied in this category

These are the sickle cell & thalassemia treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Casgevy
• Lyfgenia
• Zynteglo
• Allogeneic HSCT
• Hydroxyurea
• Adakveo

How to submit the appeal to Elevance Health

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Elevance Health cited in the denial.
3. File the appeal through Elevance Health's portal (members: https://www.anthem.com ; providers: https://providers.anthem.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In IN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Elevance Health's prior-authorization criteria by drug: Elevance Health PA criteria on ApprovalHelp.